Gary Gillheeney
Directeur Général chez ORGANOGENESIS HOLDINGS INC.
Fortune : 5 M $ au 30/04/2024
Profil
Gary S.
Gillheeney is currently the Chairman, President & Chief Executive Officer at Organogenesis, Inc. He is also the Chairman, President & Chief Executive Officer at Organogenesis Holdings, Inc. and the Director at Massachusetts Biotechnology Council.
Previously, he served as the CFO, Treasurer, Senior VP & Assistant Secretary at Providence Energy Corp.
and as the CFO, COO, Secretary & Treasurer at Innovative Clinical Solutions Ltd.
He obtained his undergraduate degree from American International College and his MBA from Bryant University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
10/04/2024 | 2 351 949 ( 1,78% ) | 5 M $ | 30/04/2024 |
Postes actifs de Gary Gillheeney
Sociétés | Poste | Début |
---|---|---|
ORGANOGENESIS HOLDINGS INC. | Directeur Général | 01/01/2014 |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Directeur Général | 01/01/2014 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Directeur/Membre du Conseil | 14/05/2018 |
Anciens postes connus de Gary Gillheeney
Sociétés | Poste | Fin |
---|---|---|
Innovative Clinical Solutions Ltd.
Innovative Clinical Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Innovative Clinical Solutions, Ltd. operated two business lines: investigative clinical site management including outcomes research, and single-specialty provider network management. The Company was founded in 1994 and was headquartered in Providence, RI. | Directeur Financier/CFO | 01/01/2002 |
Providence Energy Corp. | Directeur Financier/CFO | - |
Formation de Gary Gillheeney
American International College | Undergraduate Degree |
Bryant University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ORGANOGENESIS HOLDINGS INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Innovative Clinical Solutions Ltd.
Innovative Clinical Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Innovative Clinical Solutions, Ltd. operated two business lines: investigative clinical site management including outcomes research, and single-specialty provider network management. The Company was founded in 1994 and was headquartered in Providence, RI. | Commercial Services |
Providence Energy Corp. | Utilities |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |